Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.70)
# 2,063
Out of 4,944 analysts
299
Total ratings
57.14%
Success rate
-1.01%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $134.65 | +6.94% | 15 | Aug 6, 2025 | |
HNGE Hinge Health | Maintains: Overweight | $46 → $57 | $58.05 | -1.81% | 2 | Aug 6, 2025 | |
HCA HCA Healthcare | Maintains: Equal-Weight | $410 → $400 | $390.46 | +2.44% | 4 | Jul 28, 2025 | |
OMDA Omada Health | Initiates: Overweight | $25 | $20.09 | +24.44% | 1 | Jul 1, 2025 | |
HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $48.33 | -17.24% | 4 | Jun 11, 2025 | |
THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $171.87 | +22.19% | 3 | Jun 9, 2025 | |
VEEV Veeva Systems | Maintains: Underweight | $201 → $210 | $279.18 | -24.78% | 8 | May 29, 2025 | |
UHS Universal Health Services | Initiates: Equal-Weight | $200 | $178.51 | +12.04% | 1 | Mar 26, 2025 | |
ARDT Ardent Health | Maintains: Overweight | $24 → $22 | $12.67 | +73.64% | 2 | Jan 21, 2025 | |
AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $7.19 | +46.04% | 5 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $6 | $3.56 | +68.54% | 2 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $3.94 | +26.90% | 12 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $73.65 | +54.79% | 24 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $33.14 | +72.00% | 19 | Jun 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $65.75 | +23.19% | 23 | Jun 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $64.02 | -45.33% | 4 | May 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.93 | +20.56% | 4 | Mar 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $90.14 | +105.24% | 23 | Feb 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $206.29 | -19.05% | 23 | Jan 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $109.83 | -61.76% | 25 | Jan 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $179.04 | -11.19% | 2 | Dec 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $65.90 | +89.68% | 3 | Dec 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $309.09 | -76.61% | 22 | Dec 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $193.29 | +0.88% | 3 | Oct 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $271.81 | +79.54% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $161.21 | +83.61% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $272.54 | +35.03% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $281.99 | +81.92% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $287.10 | -4.21% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $27.07 | +225.08% | 1 | Aug 31, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $51.89 | - | 11 | Aug 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $68.73 | +169.17% | 2 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $230.52 | -7.60% | 19 | Apr 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $169.93 | -65.87% | 12 | Feb 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $237.63 | -50.76% | 15 | Jun 16, 2020 |
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $134.65
Upside: +6.94%
Hinge Health
Aug 6, 2025
Maintains: Overweight
Price Target: $46 → $57
Current: $58.05
Upside: -1.81%
HCA Healthcare
Jul 28, 2025
Maintains: Equal-Weight
Price Target: $410 → $400
Current: $390.46
Upside: +2.44%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $20.09
Upside: +24.44%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $48.33
Upside: -17.24%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $171.87
Upside: +22.19%
Veeva Systems
May 29, 2025
Maintains: Underweight
Price Target: $201 → $210
Current: $279.18
Upside: -24.78%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $178.51
Upside: +12.04%
Ardent Health
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $12.67
Upside: +73.64%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $7.19
Upside: +46.04%
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $3.56
Upside: +68.54%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $3.94
Upside: +26.90%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $73.65
Upside: +54.79%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $33.14
Upside: +72.00%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $65.75
Upside: +23.19%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $64.02
Upside: -45.33%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.93
Upside: +20.56%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $90.14
Upside: +105.24%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $206.29
Upside: -19.05%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $109.83
Upside: -61.76%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $179.04
Upside: -11.19%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $65.90
Upside: +89.68%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $309.09
Upside: -76.61%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $193.29
Upside: +0.88%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $271.81
Upside: +79.54%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $161.21
Upside: +83.61%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $272.54
Upside: +35.03%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $281.99
Upside: +81.92%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $287.10
Upside: -4.21%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $27.07
Upside: +225.08%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $51.89
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $68.73
Upside: +169.17%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $230.52
Upside: -7.60%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $169.93
Upside: -65.87%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $237.63
Upside: -50.76%